GU Flashcards
Adenocarcinoma of the urinary bladder.
Adenocarcinoma of the urinary bladder arising from the urothelial lining is an uncommon malignant neoplasm, accounting for 0.5-2.0% of all malignant vesical tumors. The histologic variants show a predominant colonic (enteric) type glandular morphology with varied histologic patterns. Based on the morphology they are clasified as follows: colonic (enteric) type, adenocarcinoma NOS, mucinous, signet ring cell (SRC), clear cell type, hepatoid, and mixed forms. These tumors are also grouped as urachal and nonurachal type (the following information is about the nonurachal type). Irrespective of the various histologic patterns, there is usually evidence of cystitis cystica et glandularis or surface glandular metaplasia in the adjacent benign urothelium. Patients usually are M and in their 6th decade. The most common clinical presentation is hematuria. ~90% of the tumors arising in exstrophied bladder are adenocarcinomas. They are also more prevalent in settings of vesical schistosomiasis. In most cases, they involve the trigone and posterior bladder wall, and tend to be unifocal. Grossly, they can have a papillary, nodular, flat, or ulcerated architecture. Some variants, especially SRC, tend to present with prominent bladder wall thickening (“linitis plastica” like) without apparent growth due to diffuse infiltration of the bladder wall by tumor cells. Microscopically, these tumors show pure glandular morphology, with well to moderately differentiated colonic-type infiltrating glands with or without abundant extracellular mucin. Bladder adenocarcinomas need to be distinguished from the more common metastatic adenocarcinoma (direct spread, lymphatic, and hematogenous). The principal primary organs to be considered include colon, prostate, female genital tract, appendix, stomach, and breast. The IHC panel used to distinguish primary vesical adenocarcinoma from metastatic colonic adenocarcinoma include: CK7 and CK20 (7 and 20 are positive in >50% of primary bladder adenos; colonic adenos are typically 7 negative and 20 positive), thrombomodulin (90% of urothelial carcinomas positive, 59% of bladder adenos positive, 0% colonic adenos positive), beta-catenin (nuclear staining in 81% of colonic adenos and 0% of bladder adenos, membranous staining in 100% of colonic adenos and 88% of bladder adenos), CDX-2 is positive in both.
Aggressive angiomyxoma.
Aggressive angiomyxoma is a rare mesenchymal tumor arising primarily in the soft tissue of the pelvis and perineum of adults. The term aggressive refers to its infiltrative nature and propensity for local recurrence, but it is an indolent tumor with low metastatic potential. F:M = 6.6:1. It occurs predominantly in women of reproductive age with a peak incidence in the 4th decade and an age range of 11 to 77. In women, it arises in the vulvovaginal region, perineum, and pelvis. In men, it arises in the inguinoscrotal region and perineum. AAM is often clinically mistaken for entities such as Bartholin cyst, vaginal or labial cyst, abscess, leiomyoma, lipoma, fibroepithelial polyp, and inguinal or perineal hernia. Grossly, AAM is unencapsulated, is poorly circumscribed, and may blend imperceptively with surrounding soft tissue. The tumor is tan-pink to tan-gray, bulky, and has a rubbery consistency with a glistening, gelatinous cut surface. Microscopically, AAM is a sparsely cellular tumor composed of pale to eosinophilic stroma studded with numerous haphazardly arranged blood vessels ranging in size from thin-walled capillaries and venules to larger muscular arteries. The stroma is myxoid with intermixed wispy collagen fibrils, scattered smooth muscle bundles, and extravasated RBCs. The tumor cells are cytologically bland and have a spindled, ovoid, or stellate appearance with ill-defined cytoplasmic borders. There is minimal to no cellular atypia and mitoses are rare. IHC shows diffuse positivity for ER, PR, vimentin, and desmin. DDx for AAM includes angiomyofibroblastoma, superficial angiomyxoma, fibroepithelial stromal polyps, myxoid lipomatous tumors, and myxoid leiomyoma.
Differential diagnosis of nephrogenic adenoma.
When the NA consists of surface lesions (papillary), the DDx includes urothelial papilloma, PUNLMP, and low-grade papillary urothelial carcinoma. When the NA involves deep lamina propria and/or superficial muscle, the DDx includes prostatic adenocarcinoma and urothelial carcinoma with bland histology. When the NA has hobnail cells or a solid growth of clear cells, the DDx includes clear cell carcinoma of the urinary bladder.
Epithelioid angiomyolipoma.
Originally believed to be a hamartomatous lesion, angiomyolipoma (AML) is currently defined as a benign mesenchymal tumor composed of a variable proportion of adipose tissue, spindle and epithelioid smooth muscle cells, and abnormal thick-walled blood vessels. AML is a member of the PEComa family. Although most AMLs arise in kidney, extrarenal AMLs are also described in various sites. The epithelioid variant of AML (EAML) is mainly characterized by a predominance of epithelioid cells. In contrast to their classical counterpart, EAMLs are now considered a potentially malignant neoplasm. EAMLs are more often associated with tuberous sclerosis complex than classical AMLs. EAMLs mimic morphologically a variety of neoplasms such as RCC, renal oncocytoma, adrenal cortical neoplasm, epithelioid smooth muscle tumor, epithelioid peripheral nerve sheath tumor, epithelioid GIST, epithelioid melanoma, hepatoblastoma, and HCC. Morphologic clues to diagnosis such as islands of mature fat and abnormal vessels should be diligently searched for in surgical specimens, and prudent use of IHC may be needed.
Examples of pseudoneoplastic lesions in the genitourinary tract (male and female) and their related neoplastic mimes.
Pseudocarcinomatous epithelial hyperplasia (adenocarcinoma and urothelial carcinoma). Postoperative spindle cell nodules (sarcomas; sarcomatoid carcinoma). Drug effects (eg, cytoxan cystitis mimicking carcinoma in situ) (urothelial carcinoma). Prostatic urethral (utricular) polyp (adenocarcinoma). Paratesticular mycobacterial pseudotumor (sarcomas). Xanthogranulomatous nephritis/cystitis/orchitis/endometritis/oophoritis (sarcomatoid carcinomas). Adenomatous and basal-cell prostatic hyperplasia (adenocarcinoma). Nodular stromal prostatic hyperplasia (low-grade sarcoma). Prostatic sclerosing adenosis (adenocarcinoma). Radiation effect on prostatic epithelium (residual adenocarcinoma). Granulomatous prostatitis/orchitis (sclerosing high-grade adenocarcinoma; sclerosing seminoma). Vaginal adenosis (adenocarcinoma). Uterine cervical mesonephric remnants (adenocarcinoma). Uterine cervical microglandular adenosis (adenocarcinoma). Ovarian stromal hyperplasia/hyperthecosis (ovarian stromal neoplasms). Nephrogenic metaplasia of bladder and urethra (adenocarcinoma). Endometriosis (adenocarcinoma).
Histologic features of nephrogenic adenoma?
A metaplastic response of urothelium to injury. Also associated with renal transplantation and intravesical bCG. Histologic features are tubules (96%) composed of a single layer of cuboidal or flattened cells with clear to eosinophilic cytoplasm, round nuclei, and fine chromatin. Other features are inflammation (95%), extension into muscle (77%), structures resembling vessels (73%), presence of adjacent urothelium (69%), peritubular sheaths (65%), prominent nucleoli (54%), cords and individual cells (46%), thyroidization of tubules (38%), blue-tinged mucinous secretions (32%), papillary configurations (19%), and signet ring-like tubules (12%). The adjacent urothelium, if present, often exhibits cuboidal metaplasia (61%) or squamous metaplasia (28%). Mitotic figures are not present.
IHC for adrenal cortical carcinoma vs pheochromocytoma?
Adrenal cortical carcinoma is synaptophysin +, chromogranin -, inhibin +, Melan-A +, calretinin +, S-100 -. Pheochromocytoma is synaptophysin +, chromogranin +, inhibin -, Melan-A -, calretinin -, S-100 reactive only in nuclei of sustentacular cells.
IHC staining of nephrogenic adenoma?
Strong and diffuse granular reactivity for P504S. Rarely shows focal PSA or PAP positivity. Frequently negative (44%) or only focally positive (44%) for CK903 (AKA 34betaE12). Positive for EMA, CK7, and PAX2. Negative for CD10 and p63.
Immunostain to distinguish muscularis mucosa from muscularis propria in urothelial CA of bladder?
Smoothelin, which is a marker of terminally differentiated smooth muscle cells, stains muscularis propria but not muscularis mucosa.
Nephrogenic adenoma.
Also called nephrogenic metaplasia. An uncommon benign lesion of the urothelial tract, characterized by a circumscribed proliferation of tubules (resembling renal tubules), cysts, and papillae lined by cells with low cuboidal to columnar epithelium. M:F = 2:1. Most occur in adults, but seen in age range 4-81 years. They commonly arise in the setting of prior urothelial injury, such as past surgery (60%), calculi (14%), or trauma (9%). Additionally, 8% of patients have a previous history of renal transplantation or BCG therapy for urothelial carcinoma of the bladder. They are most commonly seen in the urinary bladder (80%); however, urethra (12%) or ureter (8%) can also be involved.
Urachal carcinoma of the urinary bladder.
Urachal carcinoma is an uncommon tumor that can present as a bladder mass. It tends to occur in the dome and anterior bladder wall and has a male predominance. Adenocarcinoma with enteric features is the most common histologic subtype and can also show mucinous and signet ring cell variants. Diagnostic criteria for urachal carcinoma include (1) tumor in the dome; (2) absence of cystitis cystica and cystitis glandularis; (3) predominant invasion of the muscularis or deeper tissues with a sharp demarcation between the tumor and surface bladder urothelium that is free of glandular or polypoid proliferation; (4) urachal remnants within the tumor; (5) extension into the bladder wall with involvement of the space of Retzius, anterior abdominal wall, or umbilicus; and (6) no evidence of a primary neoplasm elsewhere. The previous criteria help in differentiating it from primary vesical adenocarcinomas. IHC profile is similar to primary vesical adenocarcinomas and hence is of no practical utility. The management of urachal carcinoma is typically a partial cystectomy as opposed to a radical cystectomy for primary bladder adenocarcinomas.
What are renal MESTs?
Mixed Epithelial and Stromal Tumors. Other names for this entity are: leiomyomatous renal hamartomas, congenital mesoblastic nephroma in an adult, cystic hamartoma of renal pelvis, solitary multilocular cysts of the kidney, multilocular renal cyst with mullerian-like stroma, and adult metanephric stromal tumor. Is a benign renal neoplasm of adults that has a variable admixture of epithelial and mesenchymal components. M:F = 1:10. Grossly, variably solid and cystic, tan to yellow, well-circumscribed but rarely encapsulated. Microscopically, the mesenchymal component is characterized by fascicles of spindle cells showing variable degrees of smooth muscle, fibroblastic, or myofibroblastic differentiation associated with interspersed bundles of collagen. The mesenchymal component resembling that of ovarian stroma, and focal changes of the stromal cells reminiscent of ovarian stromal cell luteinization have been described. The epithelial component is dispersed throughout the neoplasm and varies from round and regular tubules to more complex tubulopapillary structures with or without cystic dilatation. These are lined by cuboidal to flattened epithelium that may show clear cell change and a hobnail appearance. Malignant transformation, recurrence, and metastasis are rare in MESTs. For pathogenesis, the female preponderance of MEST and history of long-term estrogen replacement in females or long-term sex-steroid exposure in males, combined with frequent expression of ER and PR in the mesenchymal component suggest that steroid hormones may play a role in the evolution of these tumors. The major differential diagnosis is cystic nephroma. MESTs have a higher stromal to epithelial ratio, prominent ovarian stroma, smaller cysts with phyllodes glands pattern, and stromal luteinization. CN have a low stromal to epithelial ratio, large cysts, and thin septa. DDx also includes congenital mesoblastic nephroma and primary renal synovial sarcoma.
What are the average diameters for a normal glomerulus in newborns and adults?
Newborn, 100 um. Adult, 200-250 um. Glomeruli reach normal adult size by ~8 years of age.
What are typical staining patterns for CK7, CK20, CD10, and RCC in oncocytoma, chromophobe renal cell carcinoma, and clear cell renal cell carcinoma.
Oncocytoma: CK7 neg, ~25% are CK20 pos, ~30% are CD10 pos, RCC neg. Chromophobe renal cell carcinoma: CK7 pos, CK20 neg, 0 to 45% are CD10 pos, RCC neg. Clear cell renal cell carcinoma: CK7 neg, CK20 neg, CD10 pos, RCC pos.
What does CK AE1/AE3 cocktail stain, and what are it’s uses in prostate?
CK AE1/AE3 cocktail detects acidic (CK10, CK14-16, and CK19) and basic (CK1-CK6 and CK8) cytokeratins. Is useful in the DDx of nonspecific granulomatous prostatitis, crushed or marked inflammation, or xanthoma cells versus Gleason pattern 5 prostate carcinoma. Is also useful in diagnosing small cell proliferations in the prostate, such as small cell carcinoma, lymphoma, and rhabdomyosarcoma. In the posttreatment setting, is helpful in highlighting individual atrophic prostate cancer cells and is superior to PSA, which can be suppressed by therapy and is, therefore, not detectable by IHC posttreatment.
What is the PAX-2 marker?
The PAX-2 marker is a renal-restricted nuclear transcription factor expressed in 70-80% of metastatic clear cell RCC.
What is the RCC marker?
The RCC marker is a glycoprotein found in the brush border of the proximal tubules of the kidney. It is + in 47-85% of clear cell RCC and 60-90% of papillary RCC.
Will adrenal cortical carcinomas stain positive for cytokeratins?
Adrenal cortical carcinomas are negative for CKs in formalin-fixed tissue unless antigen retrieval techniques are utilized, and even then the tumors are only focally weakly positive.
Xanthogranulomatous pyelonephritis.
XGP is a chronic destructive granulomatous process of renal parenchyma in association with long-term urinary tract obstruction and infection. The 3 forms of XGP are diffuse, segmental, and focal. Segmental XGP is characterized by segmental involvement of the disease, and focal XGP is located within the cortex with no pelvic communication. Segmental and focal XGP can be associated with normal kidney function. F>M. Mean age is ~50, with a range of 2-84. Almost all patients are symptomatic, and the most common symptoms are flank or abdominal pain, lower urinary tract symptoms, fever, palpable mass, gross hematuria, and weight loss. The common laboratory findings are leukocytosis and anemia. Urine cultures most often reveal E. coli and P. mirabilis. On CT scan, the combination of a nonfunctioning enlarged kidney, a central calculus within a contracted renal pelvis, expansion of the calices, and inflammatory changes in the perinephric fat is strongly suggestive of XGP. Grossly, the kidney has single or multiple yellow to orange nodules, and there can be central necrosis with abscess formation, involvement of perinephric fat, diffuse cortical scarring with effacement of the normal renal architecture, and cortical atrophy. Microscopically, there is a granulomatous mixed inflammatory infiltrate with fibrosis and cholesterol clefts in the background. The inflammatory infiltrate is composed of a variable number of xanthomatous histiocytes with foamy cytoplasm, neutrophils, lymphocytes, plasma cells, and multinucleated giant cells. Also, a variable degree of renal tubular atrophy, tubular dilatation and focal squamous metaplasia of the urothelium, microabscesses, lymphoid aggregates with germinal center formation, and spindle cell proliferation can be seen. The lesion shows diffuse positivity for CD68 and vimentin, and negativity for SMA, desmin, and epithelial markers. DDx includes clear cell RCC, papillary RCC, sarcomatoid RCC, leiomyosarcoma, malakoplakia, and megalocytic interstitial nephritis.
The cytoplasm of the cells in renal oncocytomas are granular and deeply eosinophilic, reflecting the abundant, packed ___ seen at the ultrastructural level.
The cytoplasm of the cells in renal oncocytomas are granular and deeply eosinophilic, reflecting the abundant, packed mitochondria seen at the ultrastructural level. In some cases, areas of the tumor are composed of oncoblasts, which are identical to the cells of the usual oncocytoma, except that the cytoplasm is not as abundant. Focal areas of cytoplasmic clearing are not uncommon but should be focal and restricted to the areas of the central scar, representing degenerative clearing of the cytoplasm because of ischemic changes.
Can renal oncocytomas show infiltration into perinephric fat and microscopic lymphovascular invasion?
Yes. But make sure it really isn’t something else. Resample and reevaluate.
The perinuclear halos seen in chromophobe renal cell carcinoma reflect the presence of ___ around the nucleus at the ultrastructural level.
The perinuclear halos seen in chromophobe renal cell carcinoma reflect the presence of microvesicles around the nucleus at the ultrastructural level. The microvesicles, which do not have affinity to H&E staining, are thought to be related to defective mitochondriogenesis. They displace cytoplasmic organelles to the periphery of the cytoplasm, leading to prominent cell membranes.
What renal neoplasms are seen in patients with Birt-Hogg-Dube syndrome?
Patients with BHD syndrome have multifocal renal tumors that include hybrid tumors (renal oncocytoma + chromophobe RCC), oncocytomas, chromophobe RCCs, clear cell RCCs, and papillary RCCs.
Clear cell RCC arises from proximal/distal tubules, and chromophobe RCC and oncocytoma arise from proximal/distal tubules.
Clear cell RCC arises from proximal tubules, and chromophobe RCC and oncocytoma arise from distal tubules.